Evaluation of serum ATX and LPA as potential diagnostic biomarkers in patients with pancreatic cancer

BACKGROUND: Pancreatic cancer (PC) is a devastating disease that has a poor prognosis and a total 5-year survival rate of around 5%. The poor prognosis of PC is due in part to a lack of suitable biomarkers that can allow early diagnosis. The lysophospholipase autotaxin (ATX) and its product lysophos...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jiang, Li, Hongyu, Xu, Wenda, Guo, Xiaozhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877052/
https://www.ncbi.nlm.nih.gov/pubmed/33568105
http://dx.doi.org/10.1186/s12876-021-01635-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877052/
https://www.ncbi.nlm.nih.gov/pubmed/33568105
http://dx.doi.org/10.1186/s12876-021-01635-6

Ejemplares similares